BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6083796)

  • 1. [Biochemical studies on tienocarbine and related compounds].
    Schöllnhammer G; Seidel PR; Dell HD
    Arzneimittelforschung; 1984; 34(10):1254-8. PubMed ID: 6083796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
    de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
    Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of lithium on catecholamines, serotonin, and their major metabolites in discrete brain regions.
    Gottberg E; Grondin L; Reader TA
    J Neurosci Res; 1989 Mar; 22(3):338-45. PubMed ID: 2709448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the levels of dopamine, serotonin and their metabolites in the caudate nucleus of the rat.
    Russ H; Henning K; Eckhardt H; Przuntek H
    Arzneimittelforschung; 1985; 35(2):481-2. PubMed ID: 2581589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of histamine H2-receptor antagonists on concentration of noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid in rat brain.
    Nowak JZ; Pilc A
    Pol J Pharmacol Pharm; 1979; 31(4):319-23. PubMed ID: 42886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical and behavioral studies on the mode of action of oxypertine.
    Moroji T; Okuyama T; Hagino Y; Sekiguchi R
    Arzneimittelforschung; 1986 May; 36(5):804-8. PubMed ID: 2873819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic studies of the central action of zopiclone: effects on locomotor activity and brain monoamines in rats.
    Liu HJ; Sato K; Shih HC; Shibuya T; Kawamoto H; Kitagawa H
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):121-8. PubMed ID: 2581904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of inherent and drug-induced dopaminergic activity after exposure to benzo(alpha)pyrene.
    Konstandi M; Harkitis P; Thermos K; Ogren SO; Johnson EO; Tzimas P; Marselos M
    Neurotoxicology; 2007 Jul; 28(4):860-7. PubMed ID: 17570529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of conditioned fear stress on monoaminergic systems in the rat brain].
    Inoue T
    Hokkaido Igaku Zasshi; 1993 May; 68(3):377-90. PubMed ID: 7686527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain monoamines in the rhesus monkey during long-term neuroleptic administration.
    Shannak KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1980; 24():315-23. PubMed ID: 6157310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nimodipine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced depletions in the biogenic amine levels in mice.
    Gerlach M; Russ H; Winker J; Witzmann K; Traber J; Stasch JP; Riederer P; Przuntek H
    Arzneimittelforschung; 1993 Apr; 43(4):413-5. PubMed ID: 7684224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of fluperlapine compared with clozapine.
    Eichenberger E
    Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of antidepressants on the balance of biogenic amines and their metabolites in the rat brain].
    Kamysheva VA; Gankina EM; Markin VA
    Farmakol Toksikol; 1985; 48(5):22-4. PubMed ID: 2416591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.
    Hellweg R; Zueger M; Fink K; Hörtnagl H; Gass P
    Neurobiol Dis; 2007 Jan; 25(1):1-7. PubMed ID: 16990008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sub-chronic nandrolone decanoate treatment on dopaminergic and serotonergic neuronal systems in the brains of rats.
    Kurling S; Kankaanpää A; Ellermaa S; Karila T; Seppälä T
    Brain Res; 2005 May; 1044(1):67-75. PubMed ID: 15862791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
    Wong DT; Threlkeld PG; Bymaster FP
    Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.